Veeva Systems
The software that drug companies run on, from clinical trials to sales calls. Very profitable, no debt, and in the middle of moving its biggest product off Salesforce while adding AI agents.
10-K FY2026- Revenue
- $3.20B in the year to January 2026, up 16%.
- Profit
- +$916M operating income, a 29% margin.
- Debt
- None and $7.24B of cash and short-term investments.
- Watch
- 28% of revenue comes from its 10 largest customers.
- AI
- Agents in Vault built on Anthropic and Amazon models, sold to its customers.
- Hiring
- 7,928 staff up 637 in a year. Work Anywhere: office or home, day by day.
- Listings
- 769 → 707 remote listings since Oct 10.
Trials and quality now outsell sales software.
Veeva started as a CRM for drug reps. Today the bigger half is software for running clinical trials, regulatory filings, safety and quality. Almost all revenue is subscriptions; services are about a sixth.
- 1Built only for life sciences1,552 customers, and its software sits inside clinical, regulatory, safety, quality and sales work. Switching means re-validating regulated processes.10-K FY2026
- 2One platform under every productVault runs the R&D suite and now CRM. Over 180 customers are live on Vault CRM and 12 top 20 biopharmas have committed.Veeva Q2 FY2027 results
- 3A fortress balance sheet$7.24B of cash and investments and no debt. Operating cash flow was $1.37B in six months.10-Q Q2 FY2027
| Company | Worth | Revenue | Growth | Per employee | Paid per $1 | Stock, 1 yr |
|---|---|---|---|---|---|---|
| Veeva Systems | $50.7B | $3.46B | +17% | $0.44M | $14.94 | +9% |
| Salesforce | $189B | $43.9B | +11% | $0.53M | $4.28 | −9% |
| IQVIA | $44.1B | $17.3B | +9% | $0.19M | $2.58 | +24% |
| Dassault Systemes | $37.8B | $7.05B | 0% | $0.28M | $5.32 | +3% |
| Oracle | $395B | $71.8B | +22% | $0.51M | $5.46 | −51% |
- Veeva Systems
- Worth
- $50.7B
- Revenue
- $3.46B
- Growth
- +17%
- Per employee
- $0.44M
- Paid per $1
- $14.94
- Stock, 1 yr
- +9%
- Salesforce
- Worth
- $189B
- Revenue
- $43.9B
- Growth
- +11%
- Per employee
- $0.53M
- Paid per $1
- $4.28
- Stock, 1 yr
- −9%
- IQVIA
- Worth
- $44.1B
- Revenue
- $17.3B
- Growth
- +9%
- Per employee
- $0.19M
- Paid per $1
- $2.58
- Stock, 1 yr
- +24%
- Dassault Systemes
- Worth
- $37.8B
- Revenue
- $7.05B
- Growth
- 0%
- Per employee
- $0.28M
- Paid per $1
- $5.32
- Stock, 1 yr
- +3%
- Oracle
- Worth
- $395B
- Revenue
- $71.8B
- Growth
- +22%
- Per employee
- $0.51M
- Paid per $1
- $5.46
- Stock, 1 yr
- −51%
Investors pay $14.94 for every dollar Veeva Systems brings in. Its peers here range from $2.58 to $5.46, about 3.1 times their median of $4.80.
Veeva Systems brought in $928 million in 92 days.
That is about $139 million more than the same three months a year earlier. Each of its 7,928 employees brought in about $0.40 million over the year, about $1,100 a day.
Revenue is not profit. It is the money that came in before Veeva Systems pays any of its costs.
10-Q Q2 FY2027; employees from 10-K FY2026Operating profit grew from $429 million to $916 million.
Revenue grew 35% in two years. In FY2026 it kept 29 cents of every revenue dollar as operating profit.
- FY2024: kept 18¢ of every $1
- FY2025: kept 25¢ of every $1
- FY2026: kept 29¢ of every $1
Salesforce and Oracle bring in more per person than Veeva Systems; IQVIA and Dassault Systemes less.
- Salesforce$0.53M
- Oracle$0.51M
- Veeva Systems$0.44M
- Dassault Systemes$0.28M
- IQVIA$0.19M
Veeva could fund years of losses it does not have. The cash pays for buybacks and small AI acquisitions, and the interest it earns is a big part of profit.
The rest of Veeva Systems, for members.
The fine print, who gets paid most, where it looks headed and our calls. Free for 3 days, then $9 a month.
- 03
What the filings say, and what we think it means.
10 flags, each with our read
- 04
Other is paid 23% over market. Product, 21% under.
Posted pay against the market, 8 teams
- 05 · 06
How Veeva Systems uses AI, and what its hiring says.
- 07
Your view of the next year, in a share price.
- 08
The signals, and which way they push.
5 signals
- 09
Where Veeva Systems ends up, if we had to bet.
5 predictions, with odds
Read by the Still Remote research agent on November 1, 2026 from the sources linked on this page. Facts and scenarios only, not investment advice.